Business-development execs lure portfolio managers to hedge funds. Their status is rising as funds from Citadel to Point72 ...

BofA has initiated coverage of Avidity Biosciences (RNA) with a buy rating, citing multiple upcoming catalysts for the stock. Read more here.

Fintel reports that on May 3, 2024, B of A Securities initiated coverage of Avidity Biosciences ( NasdaqGM:RNA) with a Buy recommendation.

Analyst Quinn Bolton from Needham maintained a Buy rating on Silicon Motion (SIMO – Research Report) and keeping the price target at ...